Astrid Borkowski
Chief Medical Officer at HilleVax | Gladenbach, Hesse, Germany
Astrid Borkowski’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Chief Medical Officer at HilleVax in May 2021 - Present
VP, Head of Clinical Development, Takeda Vaccines at Takeda Pharmaceuticals in October 2012 - May 2021
Head Early Development, Bacterial at Novartis Vaccines and Diagnostics in March 2011 - December 2012
Head Early Development Cluster, Viral at Novartis Vaccines and Diagnostics in July 2010 - April 2011
Chief Medical Officer Europe at Novartis Vaccines and Diagnostics in September 2008 - June 2010
Chief Medical Officer Northern&Western Europe at Novartis Vaccines and Diagnostics in January 2007 - August 2008
Clinical Development Manager at GSK in January 2006 - December 2006
Clinical Team Leader at Chiron Vaccines in December 2000 - December 2005
Postdoctoral Research Fellow at Mayo Clinic in October 1998 - October 2000
Stationsaerztin at Rheumaklinik Berlin-Buch in April 1995 - September 1998
Humboldt-Universität zu Berlin, 1995, January 1988 to January 1995
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
Discover more about HilleVax
Senior Manager, Financial Reporting at HilleVax
Senior Manager, Financial Reporting at HilleVax
(December 2022 – Present)
Disruptive and Transformational Global Leader/Independent Corporate Board Member/Healthcare Advisor/Diversity and Inclusion Coach
Laminar Pharma is a biopharmaceutical company, focused on the discovery, rational design and initial clinical development of novel therapies using Membrane Lipid Therapy (MLT), which targets membrane lipids, instead of acting directly on proteins or DNA. Laminar Pharmaceutica...
Human Resource Leader
Vice President Human Resources at HilleVax
(Jan 2022 – Present)
Chief Financial Officer at HilleVax
Chief Financial Officer at HilleVax
(Jan 2023 – Present)
Director-Medical/Scientific Education,Communication and Training
• Lead the design, development and implementation of medical/scientific education and communication strategy including development of the Scientific Communication Platform (SCP) and the core content for external messaging and disease awareness campaigns
• Manage the develo...
Senior Director of Bioprocess Development
Led next-generation virus-like-particle (VLP) based vaccine products development in Hillevax
o Represented CMC function in cross-functional VLP product development team.
o Led a Phase 1 technology transfer activities between cross-continental partners.
o Tech transfer to CDMO...
What is Astrid Borkowski email address?
Email Astrid Borkowski at [email protected] and [email protected]. This email is the most updated Astrid Borkowski's email found in 2026.
How to contact Astrid Borkowski?
To contact Astrid Borkowski send an email to [email protected] or [email protected].
What company does Astrid Borkowski work for?
Astrid Borkowski works for HilleVax.
What is Astrid Borkowski's role at HilleVax?
Astrid Borkowski is Chief Medical Officer
What industry does Astrid Borkowski work in?
Astrid Borkowski works in the Pharmaceuticals industry.
